Effient Approved by the FDA
July 11, 2009 by Stephen Kersey
Filed under Business
Effient, a blood thinning drug made by Eli Lilly and Daiichi Sankyo, has been cleared by the United States Food and Drug Administration. The FDA approved Effient to be used for patients with acute coronary syndromes to reduce thrombotic cardiovascular events.
Said John Lechleiter, the CEO of Eli Lilly: “The FDA approval of Effient is a major step forward in the treatment of acute coronary syndromes. The Daiichi Sankyo/Lilly alliance has provided doctors with an important new option that provides greater protection against thrombotic cardiovascular events to help those suffering with ACS who are being managed with PCI.”
Eli Lilly is a pharmaceutical company that has more than 40,000 employees. Headquartered in the state of Indiana, Eli Lilly does business around the world.
Daiichi Sankyo is headquartered in Tokyo, Japan and has approximately 15,000 employees. It is one of the top 25 largest pharmaceutical companies in the world.
Eli Lilly (Image: Flickr)
